| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | 8A9H4VK35Z |
| Parent Compound: | TIVOZANIB |
| InChI Key | RQXMKRRBJITKRN-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H22Cl2N4O6 |
| Molecular Weight | 509.35 |
| AlogP | 5.64 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 107.74 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 32.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Platelet-derived growth factor receptor beta inhibitor | FDA |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2105756 |
| FDA SRS | 8A9H4VK35Z |
| PubChem | 11547978 |
| SureChEMBL | SCHEMBL21174286 |